219 related articles for article (PubMed ID: 18190706)
21. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
22. Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.
Zagon IS; Kreiner S; Heslop JJ; Conway AB; Morgan CR; McLaughlin PJ
Int J Oncol; 2008 Aug; 33(2):317-23. PubMed ID: 18636152
[TBL] [Abstract][Full Text] [Related]
23. Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Campbell AM; Zagon IS; McLaughlin PJ
Brain Res Bull; 2013 Jan; 90():43-51. PubMed ID: 22985690
[TBL] [Abstract][Full Text] [Related]
24. Opioid growth factor and the treatment of human pancreatic cancer: a review.
Zagon IS; McLaughlin PJ
World J Gastroenterol; 2014 Mar; 20(9):2218-23. PubMed ID: 24605021
[TBL] [Abstract][Full Text] [Related]
25. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
Zagon IS; Donahue RN; McLaughlin PJ
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1154-61. PubMed ID: 19675283
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.
Klocek MS; Sassani JW; Donahue RN; McLaughlin PJ; Zagon IS
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5054-61. PubMed ID: 20463323
[TBL] [Abstract][Full Text] [Related]
27. Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer.
Zagon IS; Donahue R; McLaughlin PJ
Exp Biol Med (Maywood); 2013 May; 238(5):579-87. PubMed ID: 23856908
[TBL] [Abstract][Full Text] [Related]
28. Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
Zagon IS; Ruth TB; McLaughlin PJ
Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):24-37. PubMed ID: 15584033
[TBL] [Abstract][Full Text] [Related]
29. Opioid growth factor regulates the cell cycle of human neoplasias.
Zagon IS; Roesener CD; Verderame MF; Ohlsson-Wilhelm BM; Levin RJ; McLaughlin PJ
Int J Oncol; 2000 Nov; 17(5):1053-61. PubMed ID: 11029512
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
McLaughlin PJ; Zagon IS; Park SS; Conway A; Donahue RN; Goldenberg D
BMC Cancer; 2009 Oct; 9():369. PubMed ID: 19835629
[TBL] [Abstract][Full Text] [Related]
31. Acute renal failure during sepsis: potential role of cell cycle regulation.
Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
[TBL] [Abstract][Full Text] [Related]
32. Chloride ions control the G1/S cell-cycle checkpoint by regulating the expression of p21 through a p53-independent pathway in human gastric cancer cells.
Miyazaki H; Shiozaki A; Niisato N; Ohsawa R; Itoi H; Ueda Y; Otsuji E; Yamagishi H; Iwasaki Y; Nakano T; Nakahari T; Marunaka Y
Biochem Biophys Res Commun; 2008 Feb; 366(2):506-12. PubMed ID: 18067855
[TBL] [Abstract][Full Text] [Related]
33. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
34. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
[TBL] [Abstract][Full Text] [Related]
36. Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
Donahue RN; McLaughlin PJ; Zagon IS
Exp Biol Med (Maywood); 2011 Sep; 236(9):1036-50. PubMed ID: 21807817
[TBL] [Abstract][Full Text] [Related]
37. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
Enomoto K; Mimura T; Harris DL; Joyce NC
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
[TBL] [Abstract][Full Text] [Related]
38. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells.
Chen X; Mo P; Li X; Zheng P; Zhao L; Xue Z; Ren G; Han G; Wang X; Fan D
Mol Carcinog; 2011 Oct; 50(10):804-10. PubMed ID: 21268134
[TBL] [Abstract][Full Text] [Related]
39. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
Todd MC; Spruill SC; Meerbrey KL
Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
[TBL] [Abstract][Full Text] [Related]
40. alpha-1,3-Fucosyltransferase-VII stimulates the growth of hepatocarcinoma cells via the cyclin-dependent kinase inhibitor p27Kip1.
Wang QY; Guo P; Duan LL; Shen ZH; Chen HL
Cell Mol Life Sci; 2005 Jan; 62(2):171-8. PubMed ID: 15666088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
